WillItSurvive

Nigerian insurtech selling digital micro-insurance policies to underserved customers.

Losing its protection
Assessed 23 July 2026 · Evidence as of 23 July 2026
The structural protection is eroding.
On the recordSince 23 July 2026 · Checkable from early 2027 · Every call on the record Checkpoint: NIIRA 2025 minimum capital deadline and window to close a Series A
The call

Casava holds a rare license that keeps AI vendors and big insurers out of its exact spot, but with no new capital in over four years and traffic collapsing, the license may outlast the company itself.

Casava sells small insurance policies in Nigeria and holds a government license to take on risk itself, which is hard for others to copy. Bigger insurers like AXA Mansard and Leadway are now building their own apps to compete, while AI companies like Curacel are selling automation software that makes digital insurance faster and cheaper for anyone. The one thing that matters most is whether Casava can raise money and meet new Nigerian capital rules by early 2027, because without fresh funding, the company's advantage from owning its license may not be enough to survive.

Why
01
AI pressure: Curacel. Curacel sells AI claims and underwriting tools to 20+ insurers, letting slower rivals match Casava's digital speed without a license. Could AI do the core job? Only partly.
02
Bigger players: AXA Mansard and Leadway Assurance. Both shipped their own apps (MyAXA Plus, Leadway app) and AXA Mansard grew revenue 20% YoY, squeezing Casava's digital-first pitch. Could a giant copy it? Probably.
03
What protects it. Its NAICOM microinsurance underwriting license lets it hold risk directly, something AI vendors and cautious incumbents can't just copy.
What would change this call
Casava announces a priced Series A round before early 2027. Shows it can fund NIIRA 2025 capital minimums and survive as an underwriter.
NAICOM revokes, suspends, or flags Casava's microinsurance license. Confirms the capital gap has become a regulatory survival threat.
AXA Mansard or Leadway launches a sub-₦10,000/year micro-premium product. Would remove Casava's low-cost niche and validate incumbent encroachment.
Key numbers
  • No funding raised in 54 months (2026-06)
  • Web traffic down 100% QoQ (2026-06)
  • AXA Mansard Q1 2026 revenue ₦48.46bn, up 20% YoY (2026-Q1)
Named risks
  • No new capital raised since February 2022 while NIIRA 2025 raises minimum capital requirements. Severity: high
  • Incumbents AXA Mansard and Leadway have shipped competing digital apps, eroding Casava's differentiation. Severity: high
  • AI infrastructure vendors like Curacel let incumbents replicate claims speed without needing a license. Severity: medium
  • Third-party trackers flagged weakened traction signals for Casava in mid-2026. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
AXA Mansard Insurancegaining onN48.46bn Q1 2026 revenue, +20% YoY, plus MyAXA Plus app as of 2026-06-30
Leadway Assurancegaining onMost-recognized Nigerian insurance brand with own Leadway App per 2026-07-01 ranking
AIICO InsurancecontestingLargest premium base at N156.1bn for FY2024
Curacelgaining onAI claims infrastructure serves 20+ insurers incl. AXA Mansard as of 2025-06-24, no license needed
Questions people ask
Is Casava profitable in 2026?
No public financials exist for Casava, a private Lagos insurtech. It has not disclosed revenue or profit, and has raised no new capital since its $4M pre-seed round closed February 2, 2022, led by Target Global.
Could AI replace Casava?
Not directly. Casava holds a NAICOM microinsurance underwriting license and bears insurance risk on its own balance sheet, something AI vendors like Curacel deliberately avoid. But Curacel's AI claims infrastructure, used by 20+ insurers including AXA Mansard as of June 2025, can copy Casava's speed edge without a license.
Who is Casava's biggest competitor?
AXA Mansard Insurance is the most direct threat: it posted N48.46bn Q1 2026 revenue, up 20% year over year as of June 30, 2026, and runs its own MyAXA Plus digital app, undercutting Casava's digital-first pitch.
Who owns Casava?
Casava is privately held and founder-led by CEO Bode Pedro. Its only disclosed funding is a $4M pre-seed round from February 2, 2022, led by Berlin's Target Global with fintech founder angels like Paystack's Shola Akinlade.
Has Casava raised any funding since its 2022 round?
No public funding round has been reported for Casava since its $4M pre-seed announced February 2, 2022, led by Target Global. No subsequent raise, valuation, or acquisition has surfaced as of mid-2026.
What insurance products does Casava sell?
Casava sells Health Cash Insurance, roughly N5,000 per year for N100,000 medical cover and N500,000 disability or death benefit, and Income Protection Insurance from $1 per month covering up to six months of income replacement.
Timeline
  • 2026-06-30AXA Mansard reports N48.46bn Q1 2026 insurance revenue, up 20% YoY
  • 2026-05-29NAICOM issues first NIIRA-era insurtech license, to CBI Partnering, not Casava
  • 2025-11-13NAICOM appoints Casava CEO Bode Pedro to its Digitization Working Group
  • 2025-08-19Casava names Solabomi Oreagba as COO amid NIIRA reform rollout
  • 2022-02-02Casava raises $4M pre-seed led by Target Global, largest African insurtech pre-seed
  • 2021-04Casava launches its digital microinsurance product
  • 2019Casava founded by Bode Pedro in Lagos
Revision history
23 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources